Neuphoria Therapeutics NEUP Balance Sheet (2020-2026)

NASDAQ NEUP
$3.76 +0.01 (+0.27%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

Neuphoria Therapeutics Quarterly Balance Sheet

Periods 15 quarters
Latest Mar 2026

Neuphoria Therapeutics reported total assets of $34.81M and total liabilities of $5.39M for the quarter ended Mar 2026, up 13.3% year over year. This balance sheet covers 15 quarters of results from Jun 2020 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Jun2020 Jun2021 Jun2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 3.00M21.95M24.04M12.20M8.14M10.15M8.43M12.61M8.08M4.34M17.04M14.21M13.65M22.20M19.44M
Short-term InvestmentsInvestments (Current) 0.34M0.08M0.08M0.08M
Cash & Current Investments 3.00M22.28M24.04M12.20M8.14M10.15M8.43M12.61M8.08M4.34M17.04M14.29M13.73M22.28M19.44M
Receivables - NetNet Receivables 0.69M0.15M0.05M0.01M0.13M0.12M0.04M0.02M0.01M0.00M1.11M1.61M
Receivables - OtherOther Receivables 0.50M0.71M4.81M0.42M0.10M0.10M0.00M0.00M237.000.00M0.49M0.81M
Receivables 1.19M0.87M4.86M0.43M0.22M0.22M0.04M0.03M0.01M0.00M1.60M2.41M
Prepaid Assets 0.80M0.46M0.23M0.02M0.02M0.74M0.22M0.03M0.61M
Current Assets 23.82M29.95M13.43M13.19M8.43M4.40M17.09M15.04M13.95M23.39M21.66M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 1.32M17.97M16.83M15.31M0.00M0.00M0.00M0.00M0.00M0.00M
Goodwill 8.44M9.55M9.22M8.75M8.57M8.84M8.63M8.69M8.90M8.41M8.45M8.64M8.67M8.74M8.84M
Intangibles 15.93M7.66M7.05M6.15M5.96M5.80M5.63M5.47M5.30M5.14M4.97M4.80M4.64M4.47M4.31M
Goodwill & Intangibles 24.37M7.66M7.05M6.15M14.54M14.64M14.26M14.16M14.21M13.54M13.42M13.44M13.31M13.21M13.15M
Long-Term Deferred Tax 23.50M27.70M26.10M
Other Non-Current Assets 0.08M0.08M0.08M0.08M0.08M0.07M0.07M0.08M0.08M0.08M
Non-Current Assets 17.97M16.83M15.31M14.46M14.49M13.77M13.62M13.55M13.39M13.21M13.15M
Assets 0.72M41.79M46.78M28.74M27.65M22.92M18.17M30.71M28.59M27.34M36.60M34.81M
Liabilities
Current Liabilities
Accounts Payables 1.52M1.40M2.00M2.34M2.24M1.33M1.53M0.75M1.15M1.37M0.52M0.63M
Payables 1.52M1.40M2.00M2.34M2.24M1.33M1.53M0.75M1.15M1.37M0.52M0.63M
Accumulated Expenses 1.19M1.46M1.10M0.79M0.68M2.95M3.67M2.07M0.89M
Other Accumulated Expenses 0.04M0.31M0.08M0.03M0.03M0.28M0.11M0.10M0.17M
Current Leases 0.11M0.12M0.13M0.12M0.12M0.12M0.09M
Total Current Liabilities 1.82M2.40M2.76M3.83M2.55M2.13M1.55M4.22M5.12M2.59M1.51M
Non-Current Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax 0.34M1.42M1.29M1.11M0.96M0.83M0.84M0.76M0.50M0.46M0.43M0.39M
Operating Leases 0.02M0.53M0.38M0.24M0.12M0.09M0.05M0.02M
Other Non-Current Liabilities 2.46M4.66M1.69M0.81M1.89M3.70M8.09M2.71M2.46M
Total Non-Current Liabilities 3.32M3.61M3.83M5.50M4.16M3.61M2.83M5.89M6.74M4.18M2.93M
Total Liabilities -7.60M5.13M6.01M6.59M-17.23M-19.50M-17.95M10.16M5.85M4.42M4.72M9.59M14.83M6.90M5.39M
Shareholder's Equity
Common Equity 8.31M36.65M40.76M22.15M17.23M19.50M17.95M17.49M17.07M13.75M26.00M19.00M12.51M29.70M29.42M
Liabilities and Shareholders Equity 0.72M41.79M46.78M28.74M27.65M22.92M18.17M30.71M28.59M27.34M36.60M34.81M
Retained Earnings -136.86M198.48M198.28M-3.74M199.37M200.19M203.56M218.32M218.39M